| abstract |
A binding compound that binds to human IL-17A comprising at least one variable region of the antibody light chain, or binding fragment thereof, having the CDR1 to CDRL3 CDR sequences of SEQ ID NO: 11- 13; and at least one variable region of the antibody heavy chain, or binding fragment thereof, having the CDRH1 to CDRH3 CDR sequences of SEQ ID NO: 14, 17 and 20 or SEQ ID NO: 14, 16 and 19 . |